SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-058177
Filing Date
2016-03-17
Accepted
2016-03-17 14:33:09
Documents
2
Period of Report
2016-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3994
2 POWER OF ATTORNEY abrams_poa.htm EX-24.1 13576
  Complete submission text file 0001140361-16-058177.txt   19102
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORP. 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Abrams Michael J. (Reporting) CIK: 0001628291 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 161512257